|
Tournier, C; Whitmarsh, A J; Cavanagh, J et al. (1999) The MKK7 gene encodes a group of c-Jun NH2-terminal kinase kinases. Mol Cell Biol 19:1569-81
|
|
Lunato, A J; Wang, J; Woollard, J E et al. (1999) Synthesis of 5-(carboranylalkylmercapto)-2'-deoxyuridines and 3-(carboranylalkyl)thymidines and their evaluation as substrates for human thymidine kinases 1 and 2. J Med Chem 42:3378-89
|
|
Cai, J; Soloway, A H; Barth, R F et al. (1997) Boron-containing polyamines as DNA targeting agents for neutron capture therapy of brain tumors: synthesis and biological evaluation. J Med Chem 40:3887-96
|
|
Soloway, A H; Barth, R F; Gahbauer, R A et al. (1997) The rationale and requirements for the development of boron neutron capture therapy of brain tumors. J Neurooncol 33:9-18
|
|
Liu, L; Barth, R F; Tjarks, W et al. (1996) In vitro and in vivo evaluation of carboranyl uridines as boron delivery agents for neutron capture therapy. Anticancer Res 16:113-20
|
|
Barth, R F; Soloway, A H; Brugger, R M (1996) Boron neutron capture therapy of brain tumors: past history, current status, and future potential. Cancer Invest 14:534-50
|
|
Barth, R F; Soloway, A H (1994) Boron neutron capture therapy of primary and metastatic brain tumors. Mol Chem Neuropathol 21:139-54
|
|
Wyzlic, I M; Tjarks, W; Soloway, A H et al. (1994) Strategies for the design and synthesis of boronated nucleic acid and protein components as potential delivery agents for neutron capture therapy. Int J Radiat Oncol Biol Phys 28:1203-13
|
|
Barth, R F; Soloway, A H; Fairchild, R G et al. (1992) Boron neutron capture therapy for cancer. Realities and prospects. Cancer 70:2995-3007
|
|
Tjarks, W; Anisuzzaman, A K; Liu, L et al. (1992) Synthesis and in vitro evaluation of boronated uridine and glucose derivatives for boron neutron capture therapy. J Med Chem 35:1628-33
|
Showing the most recent 10 out of 11 publications
